eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Depomed, Inc. - Comment

Depomed, Inc. - Comment

Document ID: FDA-2011-N-0583-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 17 2012, at 12:00 AM Eastern Standard Time
Date Posted: February 6 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: October 19 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: January 17 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80f99c51
View Document:  View as format xml

This is comment on Proposed Rule

Orphan Drug Regulations

View Comment

N/A

Attachments:

Depomed Inc Comment

Title:
Depomed Inc Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 12
Emma Rachelle Surber - Comment
Public Submission    Posted: 11/22/2011     ID: FDA-2011-N-0583-0002

Jan 17,2012 11:59 PM ET
Depomed, Inc. - Comment
Public Submission    Posted: 02/06/2012     ID: FDA-2011-N-0583-0003

Jan 17,2012 11:59 PM ET
Shire Human Genetic Therapies - Comment
Public Submission    Posted: 02/06/2012     ID: FDA-2011-N-0583-0004

Jan 17,2012 11:59 PM ET
Catholic Health Initiatives - Comment
Public Submission    Posted: 02/15/2012     ID: FDA-2011-N-0583-0005

Jan 17,2012 11:59 PM ET
GlaxoSmithKline GSK - Comment
Public Submission    Posted: 02/15/2012     ID: FDA-2011-N-0583-0006

Jan 17,2012 11:59 PM ET